Bioequivalence of Two Transdermal Clonidine Administrations in Healthy Volunteers
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
To establish the bioequivalence and adhesion properties of transdermal clonidine prepared
with Oppanol® brands of polyisobutylene (PIB) vs. transdermal clonidine prepared with
VistanexTM brands of polyisobutylene (PIB) in healthy male and female volunteers.